Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-08

Clinical Trial Update: Feasibility Trial Testing the Bionic Pancreas With ZP4207 [Phase 2]

View source ↗

Summary

Phase 2 feasibility trial assessing the Bionic Pancreas with ZP4207 for type 1 diabetes, completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bionic Pancreas with ZP4207 (ZP4207)

Snippet

Sponsor: Zealand Pharma | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: COMPLETED | Results posted: 2021-02-08